Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review

Andrea Marani1, Giulio Rizzetto1, Giulia Radi1

  • 1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60121 Ancona, Italy.

Insights

Pediatric psoriasis patients often experience metabolic issues like obesity and insulin resistance. Early awareness and tailored treatment are crucial for managing these associated health conditions in children.

Area of Science:

  • Dermatology
  • Pediatrics
  • Metabolic Syndrome

Background:

  • Psoriasis vulgaris is a chronic inflammatory skin condition.
  • It is increasingly recognized as a systemic disease with significant comorbidities.
  • Metabolic comorbidities are particularly prevalent in children with psoriasis.

Purpose of the Study:

  • To review and synthesize current knowledge on metabolic comorbidities in pediatric psoriasis.
  • To highlight the key metabolic health issues affecting children with this condition.

Main Methods:

  • This study employed a narrative review approach.
  • It synthesized existing literature on metabolic comorbidities in psoriatic children.

Main Results:

  • Obesity is a primary metabolic comorbidity in children with psoriasis.
  • Insulin resistance and type 2 diabetes are frequently observed.
  • Cardiovascular disease and dyslipidemia are also significant concerns.

Conclusions:

  • Dermatologists must recognize and actively manage metabolic comorbidities in pediatric psoriasis patients.
  • Therapeutic strategies should be individualized based on the patient's overall clinical status.
  • Addressing metabolic health is integral to comprehensive psoriasis care in children.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
71
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
488
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
277
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
51
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
49